• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于提高……基因组编辑效率的CRISPR/Cas系统的优化

Optimization of CRISPR/Cas System for Improving Genome Editing Efficiency in .

作者信息

Zhao Yuemeng, Wang Fei, Wang Changhong, Zhang Xiaobai, Jiang Cizhong, Ding Feng, Shen Li, Zhang Qingfeng

机构信息

Research Center for Translational Medicine, Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine, Shanghai, China.

Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, Tongji University, Shanghai, China.

出版信息

Front Microbiol. 2021 Jan 8;11:625862. doi: 10.3389/fmicb.2020.625862. eCollection 2020.

DOI:10.3389/fmicb.2020.625862
PMID:33488567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7819880/
Abstract

Studies of molecular mechanisms and related gene functions have long been restricted by limited genome editing technologies in malaria parasites. Recently, a simple and effective genome editing technology, the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated) system, has greatly facilitated these studies in many organisms, including malaria parasites. However, due to the special genome feature of malaria parasites, the manipulation and gene editing efficacy of the CRISPR/Cas system in this pathogen need to be improved, particularly in the human malaria parasite, . Herein, based on the CRISPR/Cas9 system, we developed an integrating strategy to generate a Cas9i system, which significantly shortened the time for generation of transgenic strains in . Moreover, with this Cas9i system, we have successfully achieved multiplexed genome editing (mutating or tagging) by a single-round transfection in . In addition, we for the first time adapted AsCpf1 ( sp. Cpf1), an alternative to Cas9, into parasites and examined it for gene editing. These optimizations of the CRISPR/Cas system will further facilitate the mechanistic research of malaria parasites and contribute to eliminating malaria in the future.

摘要

长期以来,疟原虫分子机制及相关基因功能的研究一直受到其有限的基因组编辑技术的限制。最近,一种简单有效的基因组编辑技术——CRISPR/Cas(成簇规律间隔短回文重复序列/CRISPR相关蛋白)系统,极大地促进了在包括疟原虫在内的许多生物体中的此类研究。然而,由于疟原虫特殊的基因组特征,CRISPR/Cas系统在这种病原体中的操作和基因编辑效率有待提高,特别是在人类疟原虫中。在此,基于CRISPR/Cas9系统,我们开发了一种整合策略来生成Cas9i系统,这显著缩短了在……中产生转基因菌株的时间。此外,利用这种Cas9i系统,我们成功地通过单次转染在……中实现了多重基因组编辑(突变或标记)。此外,我们首次将Cas9的替代物AsCpf1(……属Cpf1)应用于疟原虫,并对其进行基因编辑检测。CRISPR/Cas系统的这些优化将进一步促进疟原虫的机制研究,并为未来消除疟疾做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/465aed79ec85/fmicb-11-625862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/e7cdab4ee365/fmicb-11-625862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/432c44df3292/fmicb-11-625862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/12526d607193/fmicb-11-625862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/465aed79ec85/fmicb-11-625862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/e7cdab4ee365/fmicb-11-625862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/432c44df3292/fmicb-11-625862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/12526d607193/fmicb-11-625862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f85/7819880/465aed79ec85/fmicb-11-625862-g004.jpg

相似文献

1
Optimization of CRISPR/Cas System for Improving Genome Editing Efficiency in .用于提高……基因组编辑效率的CRISPR/Cas系统的优化
Front Microbiol. 2021 Jan 8;11:625862. doi: 10.3389/fmicb.2020.625862. eCollection 2020.
2
Efficient editing of malaria parasite genome using the CRISPR/Cas9 system.利用CRISPR/Cas9系统对疟原虫基因组进行高效编辑。
mBio. 2014 Jul 1;5(4):e01414-14. doi: 10.1128/mBio.01414-14.
3
CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum.利用CRISPR/Cas9基因编辑技术构建人类疟原虫恶性疟原虫的条件性突变体
J Vis Exp. 2018 Sep 18(139):57747. doi: 10.3791/57747.
4
CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact.CRISPR/Cas9 与疟原虫中的基因筛选:小基因组,大影响。
Biochem Soc Trans. 2022 Jun 30;50(3):1069-1079. doi: 10.1042/BST20210281.
5
CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector.CRISPR/Cas 技术在疟原虫基因组编辑、诊断、治疗和疫苗开发方面的进展,以及疟蚊媒介的基因工程。
Infect Genet Evol. 2023 Apr;109:105419. doi: 10.1016/j.meegid.2023.105419. Epub 2023 Feb 24.
6
CRISPR/Cas9 Genome Editing Reveals That the Intron Is Not Essential for Gene Activation or Silencing in .CRISPR/Cas9基因组编辑表明,内含子对于[具体物种或细胞类型等,原文未完整给出]中的基因激活或沉默并非必不可少。
mBio. 2017 Jul 11;8(4):e00729-17. doi: 10.1128/mBio.00729-17.
7
[Application and optimization of CRISPR/Cas system in bacteria].[CRISPR/Cas系统在细菌中的应用与优化]
Sheng Wu Gong Cheng Xue Bao. 2019 Mar 25;35(3):341-350. doi: 10.13345/j.cjb.180429.
8
Tagging to endogenous genes of Plasmodium falciparum using CRISPR/Cas9.利用 CRISPR/Cas9 对恶性疟原虫内源性基因进行标记。
Parasit Vectors. 2017 Dec 2;10(1):595. doi: 10.1186/s13071-017-2539-0.
9
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system.利用 CRISPR-Cas9 系统对人类疟原虫(Plasmodium falciparum)进行基因组编辑。
Nat Biotechnol. 2014 Aug;32(8):819-21. doi: 10.1038/nbt.2925. Epub 2014 Jun 1.
10
CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.CRISPR/Cas 系统:基因组编辑的最新进展和未来前景。
Trends Plant Sci. 2019 Dec;24(12):1102-1125. doi: 10.1016/j.tplants.2019.09.006. Epub 2019 Nov 11.

引用本文的文献

1
Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment.恶性疟原虫中通过表观遗传赋予的环状体期对青蒿素治疗的耐受性。
Nat Commun. 2025 Aug 28;16(1):8037. doi: 10.1038/s41467-025-62479-2.
2
A Conditional Cas9 System for Stage-Specific Gene Editing in .一种用于特定阶段基因编辑的条件性Cas9系统 。 (原英文文本不完整,翻译可能不太准确,需结合完整内容理解)
bioRxiv. 2025 Mar 10:2025.03.09.642268. doi: 10.1101/2025.03.09.642268.
3
transcription factor AP2-06B is mutated at high frequency in Southeast Asia but does not associate with drug resistance.

本文引用的文献

1
Actin-related protein Arp4 regulates euchromatic gene expression and development through H2A.Z deposition in blood-stage Plasmodium falciparum.肌动蛋白相关蛋白 Arp4 通过在疟原虫血期沉积 H2A.Z 来调节常染色质基因表达和发育。
Parasit Vectors. 2020 Jun 17;13(1):314. doi: 10.1186/s13071-020-04139-6.
2
The cryptic unstable transcripts are associated with developmentally regulated gene expression in blood-stage .隐蔽性不稳定转录本与血液阶段发育调控的基因表达相关。
RNA Biol. 2020 Jun;17(6):828-842. doi: 10.1080/15476286.2020.1732032. Epub 2020 Feb 27.
3
Generation and functional characterisation of Plasmodium yoelii csp deletion mutants using a microhomology-based CRISPR/Cas9 method.
转录因子AP2-06B在东南亚地区高频突变,但与耐药性无关。
Front Cell Infect Microbiol. 2025 Jan 6;14:1521152. doi: 10.3389/fcimb.2024.1521152. eCollection 2024.
4
Exploring Genetic Silencing: RNAi and CRISPR-Cas Potential against Drug Resistance in Malaria.探索基因沉默:RNA干扰和CRISPR-Cas技术对抗疟疾耐药性的潜力
Mini Rev Med Chem. 2025;25(2):128-137. doi: 10.2174/0113895575306957240610102626.
5
Ring-stage growth arrest: Metabolic basis of artemisinin tolerance in .环状体期生长停滞:青蒿素耐受性的代谢基础 于……中
iScience. 2022 Dec 5;26(1):105725. doi: 10.1016/j.isci.2022.105725. eCollection 2023 Jan 20.
6
Clustered Regularly Interspaced Short Palindromic Repeats/ CRISPR associated protein 9-mediated editing of Schistosoma mansoni genes: Identifying genes for immunologically potent drug and vaccine development.丛集规律间隔短回文重复序列/ CRISPR 相关蛋白 9 介导的曼氏血吸虫基因编辑:鉴定具有免疫效力的药物和疫苗开发基因。
Rev Soc Bras Med Trop. 2022 Aug 12;55:e0131. doi: 10.1590/0037-8682-0131-2022. eCollection 2022.
7
Genome-wide landscape of ApiAP2 transcription factors reveals a heterochromatin-associated regulatory network during Plasmodium falciparum blood-stage development.全基因组 ApiAP2 转录因子景观揭示了疟原虫血期发育过程中与异染色质相关的调控网络。
Nucleic Acids Res. 2022 Apr 8;50(6):3413-3431. doi: 10.1093/nar/gkac176.
8
PfAP2-EXP2, an Essential Transcription Factor for the Intraerythrocytic Development of .PfAP2-EXP2,一种疟原虫红细胞内发育所必需的转录因子 。(你提供的原文似乎不完整,翻译可能会存在一定局限性)
Front Cell Dev Biol. 2022 Jan 10;9:782293. doi: 10.3389/fcell.2021.782293. eCollection 2021.
9
Non-coding RNAs in malaria infection.疟疾感染中的非编码RNA
Wiley Interdiscip Rev RNA. 2022 May;13(3):e1697. doi: 10.1002/wrna.1697. Epub 2021 Oct 14.
10
FnCas12a/crRNA-Mediated Genome Editing in .FnCas12a/CRRNA介导的基因组编辑在……中
Front Genet. 2021 Sep 22;12:738746. doi: 10.3389/fgene.2021.738746. eCollection 2021.
利用基于微同源性的 CRISPR/Cas9 方法生成和功能表征疟原虫 yoelii csp 缺失突变体。
Int J Parasitol. 2019 Aug;49(9):705-714. doi: 10.1016/j.ijpara.2019.04.003. Epub 2019 Jun 13.
4
A Cas9 transgenic Plasmodium yoelii parasite for efficient gene editing.一种用于高效基因编辑的Cas9转基因约氏疟原虫寄生虫。
Mol Biochem Parasitol. 2018 Jun;222:21-28. doi: 10.1016/j.molbiopara.2018.04.003. Epub 2018 Apr 21.
5
Base editing with a Cpf1-cytidine deaminase fusion.使用 Cpf1-胞嘧啶脱氨酶融合进行碱基编辑。
Nat Biotechnol. 2018 Apr;36(4):324-327. doi: 10.1038/nbt.4102. Epub 2018 Mar 19.
6
Tagging to endogenous genes of Plasmodium falciparum using CRISPR/Cas9.利用 CRISPR/Cas9 对恶性疟原虫内源性基因进行标记。
Parasit Vectors. 2017 Dec 2;10(1):595. doi: 10.1186/s13071-017-2539-0.
7
Generating conditional gene knockouts in Plasmodium - a toolkit to produce stable DiCre recombinase-expressing parasite lines using CRISPR/Cas9.利用 CRISPR/Cas9 在疟原虫中生成条件性基因敲除——一种使用 DiCre 重组酶稳定表达寄生虫系的工具包。
Sci Rep. 2017 Jun 20;7(1):3881. doi: 10.1038/s41598-017-03984-3.
8
Engineered Cpf1 variants with altered PAM specificities.具有改变的PAM特异性的工程化Cpf1变体。
Nat Biotechnol. 2017 Aug;35(8):789-792. doi: 10.1038/nbt.3900. Epub 2017 Jun 5.
9
Rapid inducible protein displacement in and using knocksideways technology.使用敲侧向技术在[具体内容1]和[具体内容2]中实现快速诱导蛋白置换。 (注:原文中“in and ”部分内容缺失,以上是根据格式推测的完整译文表述方式)
Wellcome Open Res. 2017 Mar 14;2:18. doi: 10.12688/wellcomeopenres.11005.1.
10
A genetic system to study Plasmodium falciparum protein function.一种用于研究恶性疟原虫蛋白功能的遗传系统。
Nat Methods. 2017 Apr;14(4):450-456. doi: 10.1038/nmeth.4223. Epub 2017 Mar 13.